Trials / Completed
CompletedNCT00884169
Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This study is to investigate the efficacy and safety of M518101 in male and female plaque psoriasis patients with refractory plaques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | M518101 | Proper quantity twice a day |
| DRUG | placebo | Proper quantity twice a day |
Timeline
- Start date
- 2009-07-01
- Completion
- 2009-12-01
- First posted
- 2009-04-20
- Last updated
- 2010-11-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00884169. Inclusion in this directory is not an endorsement.